Mason Michael B
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Mason Michael B. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| WW | Award / Grant | 1,219 | — | — | Dec 19, 2025 | |
| LLY | EVP & Pres., Lilly Diabetes | Award / Grant | 8,023 | $345.12 | $2,768,898 | Feb 10, 2023 |
| LLY | EVP & Pres., Lilly Diabetes | Tax Withholding | 2,935 | $344.15 | $1,010,080 | Feb 1, 2023 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Award / Grant | 2,612 | $243.27 | $635,421 | Feb 9, 2022 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Award / Grant | 6,350 | $205.77 | $1,306,640 | Feb 8, 2021 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Option Exercise | 6,244 | — | — | Sep 1, 2020 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Award / Grant | 5,785 | $144.25 | $834,486 | Feb 11, 2020 |